{"name": "Cephalon",
 "permalink": "cephalon",
 "crunchbase_url": "http://www.crunchbase.com/company/cephalon",
 "homepage_url": "http://www.cephalon.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "orporatecommunications@cephalon.com",
 "phone_number": "610-344-0200",
 "description": "",
 "created_at": "Wed Feb 24 03:06:41 UTC 2010",
 "updated_at": "Wed Mar 30 03:49:16 UTC 2011",
 "overview": "\u003Cp\u003ECephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world\u0026#8217;s fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S\u0026amp;P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       46],
      "assets/images/resized/0007/7997/77997v1-max-150x150.jpg"],
     [[233,
       73],
      "assets/images/resized/0007/7997/77997v1-max-250x250.jpg"],
     [[233,
       73],
      "assets/images/resized/0007/7997/77997v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman \u0026 CEO",
    "person":
     {"first_name": "Frank",
      "last_name": "Baldino, Jr.",
      "permalink": "frank-baldino-jr",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "J.",
      "last_name": "Kevin Buchi",
      "permalink": "j-kevin-buchi",
      "image": null}},
   {"is_past": true,
    "title": "Director, Corporation Communications \u0026 Investor Relations",
    "person":
     {"first_name": "Nicole",
      "last_name": "Vitullo",
      "permalink": "nicole-vitullo",
      "image":
       {"available_sizes":
         [[[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-150x150.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-250x250.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "e",
      "source_url": "http://www.symbiopharma.com/en/news/110225e.pdf",
      "source_description": "SymBio Pharmaceuticals Successfully Completes JPY2.0 Billion (USD24 Million) Series E Private Placement",
      "raised_amount": 24000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2011,
      "funded_month": 2,
      "funded_day": 25,
      "company":
       {"name": "SymBio Pharmaceuticals",
        "permalink": "symbio-pharmaceuticals",
        "image":
         {"available_sizes":
           [[[150,
              72],
             "assets/images/resized/0012/4055/124055v1-max-150x150.jpg"],
            [[182,
              88],
             "assets/images/resized/0012/4055/124055v1-max-250x250.jpg"],
            [[182,
              88],
             "assets/images/resized/0012/4055/124055v1-max-450x450.jpg"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 250000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.fiercebiotech.com/story/cephalon-pays-250m-snare-ception-therapeutics/2010-02-23?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Cephalon pays $250M to snare Ception Therapeutics",
    "acquired_year": 2010,
    "acquired_month": 2,
    "acquired_day": 23,
    "company":
     {"name": "Ception Therapeutics",
      "permalink": "ception-therapeutics",
      "image":
       {"available_sizes":
         [[[149,
            150],
           "assets/images/resized/0007/7999/77999v1-max-150x150.png"],
          [[191,
            192],
           "assets/images/resized/0007/7999/77999v1-max-250x250.png"],
          [[191,
            192],
           "assets/images/resized/0007/7999/77999v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": 525000000.0,
    "price_currency_code": "USD",
    "term_code": "cash_and_stock",
    "source_url": "http://www.cephalon.com/media/news-releases.html?mode=year\u0026filterval=2011",
    "source_description": "Cephalon Announces Definitive Agreement to Acquire Gemin X",
    "acquired_year": 2011,
    "acquired_month": 3,
    "acquired_day": 21,
    "company":
     {"name": "Gemin X Pharmaceuticals",
      "permalink": "gemin-x-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            41],
           "assets/images/resized/0007/9935/79935v1-max-150x150.jpg"],
          [[250,
            68],
           "assets/images/resized/0007/9935/79935v1-max-250x250.jpg"],
          [[263,
            72],
           "assets/images/resized/0007/9935/79935v1-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 225000000.0,
    "price_currency_code": "USD",
    "term_code": "cash_and_stock",
    "source_url": "http://www.lifescientist.com.au/article/381362/chemgenex_acquired_by_cephalon/?fp=4\u0026fpid=1016",
    "source_description": "ChemGenex to be acquired by Cephalon",
    "acquired_year": 2011,
    "acquired_month": 3,
    "acquired_day": 29,
    "company":
     {"name": "ChemGenex Pharmaceuticals",
      "permalink": "chemgenex-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            130],
           "assets/images/resized/0012/8368/128368v1-max-150x150.png"],
          [[174,
            151],
           "assets/images/resized/0012/8368/128368v1-max-250x250.png"],
          [[174,
            151],
           "assets/images/resized/0012/8368/128368v1-max-450x450.png"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "41 Moores Road",
    "address2": "",
    "zip_code": "19355 ",
    "city": "Frazer",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Cephalon Exercises its Option to Acquire BioAssets Development Corporation",
    "stoned_year": 2010,
    "stoned_month": 10,
    "stoned_day": 21,
    "source_url": "http://www.cephalon.com/media/news-releases.shtml?mode=year\u0026reqid=1485861\u0026ignorequerystr=true",
    "source_text": "",
    "source_description": "Cephalon Exercises its Option to Acquire BioAssets Development Corporation",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cephalon",
      "permalink": "cephalon"}},
   {"description": "Cephalon Signs Option Agreement To Acquire Assets From Alba Therapeutics",
    "stoned_year": 2011,
    "stoned_month": 2,
    "stoned_day": 9,
    "source_url": "http://www.dailymarkets.com/stock/2011/02/09/cephalon-signs-option-agreement-to-acquire-assets-from-alba-therapeutics/",
    "source_text": "",
    "source_description": "Cephalon Signs Option Agreement To Acquire Assets From Alba Therapeutics",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cephalon",
      "permalink": "cephalon"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:CEPH"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        86],
       "assets/images/resized/0007/7996/77996v1-max-150x150.jpg"],
      [[250,
        144],
       "assets/images/resized/0007/7996/77996v1-max-250x250.jpg"],
      [[450,
        260],
       "assets/images/resized/0007/7996/77996v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}